Hematopoietic Stem Cell Transplantation or HSCT may be defined as an intense chemotherapy treatment for Multiple Sclerosis that aims to reset the immune system by wiping it out and regrowing it using stem cells.
HSCT is the procedure of intravenous infusion of Hematopoietic Stem Cells to reestablish blood cell production in patients whose bone marrow or immune system is damaged or defective.
Patients undergoing Hematopoietic Stem Cell Transplantation need 3 to 6 months to fully recover, while other causes might need a year. With regards to the success rate; 99% of patient treatment with Hematopoietic Stem Cell Transplantation had no relapses for one year and 94% of patients didn’t see their disability getting worse for three years.
The sole disadvantage of Hematopoietic Stem Cell Transplantation procedure is body rejection of donated stem cells, which lead to severe complications and the need for additional medical treatment.
At the Department of Vascular Surgery at Al Salam Hospital, the patient is the focus of all our activities; whereas depending on the individual situation, treatment options vary from minimally invasive peripheral interventions to complex vascular surgery, which are all provided in the department facilities that are equipped with a full range of modern technologies to perform surgical and endovascular procedures, in addition to various medical therapies. The Department includes a multidisciplinary team of healthcare professionals always seeking to stay up to date with the latest vascular surgery research and technology; including Cardiology, Radiology, and Interventional Radiology in order to provide you with the optimal treatment solution from a single source.
References:
- Medscape
- National Institute of Health, 2022
- MS Society
